首页 > 最新文献

Milbank Quarterly最新文献

英文 中文
Experiences and Interest in Value-Based Payment Arrangements for Medical Products Among Medicaid Agencies: An Exploratory Analysis. 医疗补助机构对基于价值的医疗产品支付安排的经验和兴趣:探索性分析。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-09-01 Epub Date: 2024-06-07 DOI: 10.1111/1468-0009.12703
Beena Bhuiyan Khan, Victoria Gemme, Ethan Chupp, Aparna Higgins, Corinna Sorenson
<p><p>Policy Points State Medicaid experience with value-based payment (VBP) arrangements for medical products is still relatively limited, and states face a number of challenges in designing and implementing such arrangements, particularly because of the resource-intensive nature of arrangements and data needed to support measurement of desired outcomes. A number of success factors and opportunities to support VBP arrangement efforts were identified through this study, including leveraging established venues or processes for collaboration with manufacturers, engaging external and internal partners in VBP efforts to bolster capabilities, acquiring access to new data sources, and utilizing annual renegotiation of contracts to allow for adjustments.</p><p><strong>Context: </strong>To date, uptake of value-based payment (VBP) arrangements for medical products and knowledge of their design and impact have been mainly concentrated among private payers. Interest and activity are expanding to Medicaid; however, their experiences and approaches to VBP arrangements for medical products are not well characterized.</p><p><strong>Methods: </strong>This study sought to characterize the use of VBP arrangements for medical products among state Medicaid agencies through the use of a two-staged, mixed-methods approach. A survey and semistructured interviews were conducted to gain an understanding of state experiences with VBP arrangements for medical products. The survey and interviews were directed at senior leaders from nine states through the survey, with respondents from seven of these states additionally participating in the semistructured interviews.</p><p><strong>Findings: </strong>Although experience with VBP arrangements for medical products among states varied, there were similarities across their motivations and general processes or phases employed in their design and implementation. States collectively identified a number of significant challenges to VBP arrangements, such as manufacturer engagement, outcomes measurement, and the time, expertise, and resources required to design and implement them. We outline a range of strategies to help address these gaps and make it easier for states to pursue VBP arrangements, including more direct engagement from the Center for Medicare and Medicaid Services, state-to-state peer learning and collaboration, data infrastructure and sharing, and additional research to inform fit-for-purpose VBP arrangement approaches.</p><p><strong>Conclusions: </strong>Findings from this study suggest that it may be easier for states to pursue VBP arrangements for medical products if there is greater clarity on processes employed that support design and implementation as well as effective strategies to address common challenges associated with contract negotiations. As states gain more experience, it will be important to monitor the design and implementation of common VBP arrangements to assess impact on the Medicaid program and th
政策要点 各州医疗补助计划在医疗产品的基于价值的支付(VBP)安排方面的经验仍然相对有限,各州在设计和实施此类安排时面临着许多挑战,特别是由于安排的资源密集性以及支持衡量预期结果所需的数据。本研究发现了一些成功的因素和机会,以支持 VBP 安排工作,包括利用既定的渠道或流程与制造商合作,让外部和内部合作伙伴参与 VBP 工作以增强能力,获取新的数据源,以及利用每年重新谈判合同以进行调整:迄今为止,医疗产品的价值付费(VBP)安排以及对其设计和影响的了解主要集中在私营支付方。然而,他们在医疗产品的价值为本付费安排方面的经验和方法并没有得到很好的描述:本研究试图通过使用两阶段混合方法来描述各州医疗补助机构对医疗产品 VBP 安排的使用情况。通过调查和半结构化访谈,了解各州在医疗产品自愿购买计划安排方面的经验。调查和访谈针对九个州的高层领导,其中七个州的受访者还参加了半结构式访谈:尽管各州在医疗产品 VBP 安排方面的经验各不相同,但其动机以及在设计和实施过程中采用的一般流程或阶段却有相似之处。各州共同发现了 VBP 安排所面临的一些重大挑战,如制造商参与、结果衡量,以及设计和实施 VBP 所需的时间、专业知识和资源。我们概述了一系列策略,以帮助解决这些差距,使各州更容易实施 VBP 安排,包括医疗保险和医疗补助服务中心更直接的参与、州与州之间的同行学习与合作、数据基础设施和共享,以及开展更多研究,为适合目的的 VBP 安排方法提供信息:本研究的结果表明,如果各州对支持设计和实施的流程以及应对与合同谈判相关的常见挑战的有效策略有更清晰的认识,那么各州可能会更容易实施医疗产品的 VBP 安排。随着各州积累更多经验,对常见 VBP 安排的设计和实施进行监控以评估其对医疗补助计划及其服务人群的影响将非常重要。
{"title":"Experiences and Interest in Value-Based Payment Arrangements for Medical Products Among Medicaid Agencies: An Exploratory Analysis.","authors":"Beena Bhuiyan Khan, Victoria Gemme, Ethan Chupp, Aparna Higgins, Corinna Sorenson","doi":"10.1111/1468-0009.12703","DOIUrl":"10.1111/1468-0009.12703","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Policy Points State Medicaid experience with value-based payment (VBP) arrangements for medical products is still relatively limited, and states face a number of challenges in designing and implementing such arrangements, particularly because of the resource-intensive nature of arrangements and data needed to support measurement of desired outcomes. A number of success factors and opportunities to support VBP arrangement efforts were identified through this study, including leveraging established venues or processes for collaboration with manufacturers, engaging external and internal partners in VBP efforts to bolster capabilities, acquiring access to new data sources, and utilizing annual renegotiation of contracts to allow for adjustments.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Context: &lt;/strong&gt;To date, uptake of value-based payment (VBP) arrangements for medical products and knowledge of their design and impact have been mainly concentrated among private payers. Interest and activity are expanding to Medicaid; however, their experiences and approaches to VBP arrangements for medical products are not well characterized.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This study sought to characterize the use of VBP arrangements for medical products among state Medicaid agencies through the use of a two-staged, mixed-methods approach. A survey and semistructured interviews were conducted to gain an understanding of state experiences with VBP arrangements for medical products. The survey and interviews were directed at senior leaders from nine states through the survey, with respondents from seven of these states additionally participating in the semistructured interviews.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Findings: &lt;/strong&gt;Although experience with VBP arrangements for medical products among states varied, there were similarities across their motivations and general processes or phases employed in their design and implementation. States collectively identified a number of significant challenges to VBP arrangements, such as manufacturer engagement, outcomes measurement, and the time, expertise, and resources required to design and implement them. We outline a range of strategies to help address these gaps and make it easier for states to pursue VBP arrangements, including more direct engagement from the Center for Medicare and Medicaid Services, state-to-state peer learning and collaboration, data infrastructure and sharing, and additional research to inform fit-for-purpose VBP arrangement approaches.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Findings from this study suggest that it may be easier for states to pursue VBP arrangements for medical products if there is greater clarity on processes employed that support design and implementation as well as effective strategies to address common challenges associated with contract negotiations. As states gain more experience, it will be important to monitor the design and implementation of common VBP arrangements to assess impact on the Medicaid program and th","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"713-731"},"PeriodicalIF":4.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Legal Landscape for Opioid Treatment Agreements. 阿片类药物治疗协议的法律前景。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-09-01 Epub Date: 2024-05-10 DOI: 10.1111/1468-0009.12699
Larisa Svirsky, Dana Howard, Martin Fried, Nathan Richards, Nicole Thomas, Patricia J Zettler

Policy Points Opioid treatment agreements (OTAs) are controversial because of the lack of evidence that their use reduces opioid-related harms and the potential risks they pose of stigmatizing patients and undermining the clinician-patient relationship. Even so, their use is now required in most jurisdictions, and their use is influencing the outcomes of civil and criminal lawsuits. More research is needed to evaluate how OTAs are implemented given existing requirements. If additional research does not resolve the current level of uncertainty regarding OTA benefits, then policymakers in jurisdictions where they are required should consider eliminating OTA mandates or providing flexibility in the legal requirements to make room for clinicians and health care institutions to implement best practices.

Context: Opioid treatment agreements (OTAs) are documents that clinicians present to patients when prescribing opioids that describe the risks of opioids and specify requirements that patients must meet to receive their medication. Notwithstanding a lack of evidence that OTAs effectively mitigate opioids' risks, professional organizations recommend that they be implemented, and jurisdictions increasingly require them. We sought to identify the jurisdictions that require OTAs, how OTAs might affect the outcomes of lawsuits that arise when things go wrong, and instances in which the law permits flexibility for clinicians and health care institutions to adopt best practices.

Methods: We surveyed the laws and regulations of all 50 states and the District of Columbia to identify which jurisdictions require the use of OTAs, the circumstances in which OTA use is mandatory, and the terms OTAs must include (if any). We also surveyed criminal and civil judicial decisions in which OTAs were discussed as evidence on which a court relied to make its decision to determine how OTA use influences litigation outcomes.

Findings: Results show that a slight majority (27) of jurisdictions now require OTAs. With one exception, the jurisdictions' requirements for OTA use are triggered at least in part by long-term prescribing. There is otherwise substantial variation and flexibility within OTA requirements. Results also show that even in jurisdictions where OTA use is not required by statute or regulation, OTA use can inform courts' reasoning in lawsuits involving patients or clinicians. Sometimes, but not always, OTA use legally protects clinicians from liability.

Conclusions: Our results show that OTA use is entwined with legal obligations in various ways. Clinicians and health care institutions should identify ways for OTAs to enhance clinician-patient relationships and patient care within the bounds of relevant legal requirements and risks.

政策要点 阿片类药物治疗协议(OTAs)备受争议,因为缺乏证据表明使用该协议可以减少与阿片类药物相关的伤害,而且该协议可能会给患者带来耻辱,破坏临床医生与患者之间的关系。尽管如此,目前大多数司法管辖区都要求使用这种药物,而且这种药物的使用正在影响民事和刑事诉讼的结果。需要进行更多的研究,以评估在现有要求下如何实施 OTA。如果更多的研究不能解决目前关于 OTA 益处的不确定性,那么要求使用 OTA 的司法管辖区的政策制定者应考虑取消 OTA 强制规定,或在法律要求中提供灵活性,为临床医生和医疗机构实施最佳实践留出空间:阿片类药物治疗协议(OTA)是临床医生在开具阿片类药物处方时向患者出示的文件,其中描述了阿片类药物的风险,并明确了患者接受药物治疗必须满足的要求。尽管缺乏证据表明 OTA 能有效降低阿片类药物的风险,但专业组织建议实施 OTA,而且越来越多的司法管辖区要求实施 OTA。我们试图确定哪些司法管辖区要求实施 OTA,OTA 如何影响出错时的诉讼结果,以及在哪些情况下法律允许临床医生和医疗机构灵活采用最佳实践:我们调查了美国所有 50 个州和哥伦比亚特区的法律法规,以确定哪些司法管辖区要求使用 OTA,在哪些情况下必须使用 OTA,以及 OTA 必须包括哪些条款(如有)。我们还调查了刑事和民事司法判决书,在这些判决书中,法院将 OTA 作为做出判决所依赖的证据进行了讨论,以确定 OTA 的使用如何影响诉讼结果:结果显示,略占多数的司法管辖区(27 个)现在都要求使用 OTA。除一个辖区外,其他辖区对使用 OTA 的要求至少部分是由长期处方引发的。除此之外,在 OTA 要求方面还有很大的差异和灵活性。结果还显示,即使在法规或条例没有要求使用 OTA 的司法管辖区,在涉及患者或临床医生的诉讼中,OTA 的使用也能为法院的推理提供参考。有时,但并非总是如此,OTA 的使用可以从法律上保护临床医生免于承担责任:我们的研究结果表明,OTA 的使用以各种方式与法律义务纠缠在一起。临床医生和医疗机构应在相关法律要求和风险的范围内确定使用 OTA 的方法,以加强临床医生与患者之间的关系和对患者的护理。
{"title":"The Legal Landscape for Opioid Treatment Agreements.","authors":"Larisa Svirsky, Dana Howard, Martin Fried, Nathan Richards, Nicole Thomas, Patricia J Zettler","doi":"10.1111/1468-0009.12699","DOIUrl":"10.1111/1468-0009.12699","url":null,"abstract":"<p><p>Policy Points Opioid treatment agreements (OTAs) are controversial because of the lack of evidence that their use reduces opioid-related harms and the potential risks they pose of stigmatizing patients and undermining the clinician-patient relationship. Even so, their use is now required in most jurisdictions, and their use is influencing the outcomes of civil and criminal lawsuits. More research is needed to evaluate how OTAs are implemented given existing requirements. If additional research does not resolve the current level of uncertainty regarding OTA benefits, then policymakers in jurisdictions where they are required should consider eliminating OTA mandates or providing flexibility in the legal requirements to make room for clinicians and health care institutions to implement best practices.</p><p><strong>Context: </strong>Opioid treatment agreements (OTAs) are documents that clinicians present to patients when prescribing opioids that describe the risks of opioids and specify requirements that patients must meet to receive their medication. Notwithstanding a lack of evidence that OTAs effectively mitigate opioids' risks, professional organizations recommend that they be implemented, and jurisdictions increasingly require them. We sought to identify the jurisdictions that require OTAs, how OTAs might affect the outcomes of lawsuits that arise when things go wrong, and instances in which the law permits flexibility for clinicians and health care institutions to adopt best practices.</p><p><strong>Methods: </strong>We surveyed the laws and regulations of all 50 states and the District of Columbia to identify which jurisdictions require the use of OTAs, the circumstances in which OTA use is mandatory, and the terms OTAs must include (if any). We also surveyed criminal and civil judicial decisions in which OTAs were discussed as evidence on which a court relied to make its decision to determine how OTA use influences litigation outcomes.</p><p><strong>Findings: </strong>Results show that a slight majority (27) of jurisdictions now require OTAs. With one exception, the jurisdictions' requirements for OTA use are triggered at least in part by long-term prescribing. There is otherwise substantial variation and flexibility within OTA requirements. Results also show that even in jurisdictions where OTA use is not required by statute or regulation, OTA use can inform courts' reasoning in lawsuits involving patients or clinicians. Sometimes, but not always, OTA use legally protects clinicians from liability.</p><p><strong>Conclusions: </strong>Our results show that OTA use is entwined with legal obligations in various ways. Clinicians and health care institutions should identify ways for OTAs to enhance clinician-patient relationships and patient care within the bounds of relevant legal requirements and risks.</p>","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"632-668"},"PeriodicalIF":4.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576586/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140899290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State-Level Education Quality and Trajectories of Cognitive Function by Race and Educational Attainment. 州级教育质量与按种族和受教育程度划分的认知功能轨迹》(State-Level Education Quality and Trajectories of Cognitive Function by Race and Educational Attainment)。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-09-01 Epub Date: 2024-07-10 DOI: 10.1111/1468-0009.12709
Katrina M Walsemann, Heide Jackson, Emily Abbruzzi, Jennifer A Ailshire

Policy Points Education-cognition research overlooks the role of education quality in shaping cognitive function at midlife and older ages, even though quality may be more responsive to federal and state investment in public schooling than attainment. For older US adults who attended school during the early to mid-20th century, the quality of US education improved considerably as federal and state investment increased. Ensuring access to high-quality primary and secondary education may protect against poor cognitive function at midlife and older ages, particularly among Black Americans and persons who complete less education. It may also play an important role in reducing health inequities.

Context: Although educational attainment is consistently associated with better cognitive function among older adults, we know little about how education quality is related to cognitive function. This is a key gap in the literature given that the quality of US education improved considerably during the early to mid-20th century as state and federal investment increased. We posit that growing up in states with higher-quality education systems may protect against poor cognitive function, particularly among Black adults and adults who completed fewer years of school.

Methods: We used prospective data on cognitive function from the Health and Retirement Study linked to historical data on state investment in public schools, restricting our sample to non-Hispanic White and Black adults born between 1914 and 1959 (19,096 White adults and 4,625 Black adults). Using race-stratified linear mixed models, we considered if state-level education quality was associated with level and decline in cognitive function and if these patterns differed by years of schooling and race.

Findings: Residing in states with higher-resourced education systems during childhood was associated with better cognitive function, particularly among those who completed less than 12 years of schooling, regardless of race. For White adults, higher-resourced state education systems were associated with higher scores of total cognitive function and episodic memory, but there were diminishing returns as resources increased to very high levels. For Black adults, the relationship between state education resources and cognitive function varied by age with positive associations in midlife and generally null or negative associations at the oldest ages.

Conclusions: Federal and state investment in public schools may provide students with opportunities to develop important cognitive resources during schooling that translate into better cognitive function in later life, especially among marginalized populations.

政策要点 教育-认知研究忽视了教育质量在塑造中老年认知功能方面的作用,尽管教育质量可能比学业成绩更能反映联邦和州对公立学校教育的投资。对于 20 世纪早期至中期上学的美国老年人来说,随着联邦和州政府投资的增加,美国的教育质量有了很大提高。确保获得高质量的初等和中等教育,可防止中年和老年时认知功能低下,尤其是美国黑人和受教育程度较低的人。它还可能在减少健康不平等方面发挥重要作用:尽管受教育程度一直与老年人认知功能的改善相关,但我们对教育质量与认知功能的关系却知之甚少。鉴于美国的教育质量在 20 世纪早期到中期随着州政府和联邦政府投资的增加而大幅提高,这是文献中的一个重要空白。我们认为,在教育系统质量较高的州长大可能会避免认知功能低下,尤其是在黑人成年人和受教育年限较短的成年人中:我们使用了《健康与退休研究》(Health and Retirement Study)中有关认知功能的前瞻性数据以及各州对公立学校投资的历史数据,并将样本限制为 1914 年至 1959 年间出生的非西班牙裔白人和黑人成年人(19096 名白人成年人和 4625 名黑人成年人)。利用种族分层线性混合模型,我们研究了州一级的教育质量是否与认知功能的水平和下降有关,以及这些模式是否因受教育年限和种族而有所不同:无论种族如何,童年时期居住在教育资源较丰富的州与认知功能较好有关,特别是在那些完成学校教育少于 12 年的人中。对于白人成年人来说,资源较丰富的州教育系统与较高的认知功能总分和外显记忆分数有关,但当资源增加到非常高的水平时,回报就会递减。对于黑人成年人来说,州教育资源与认知功能之间的关系因年龄而异,中年时呈正相关,而在最年长时一般呈负相关:结论:联邦和州对公立学校的投资可为学生提供机会,在学校教育期间开发重要的认知资源,这些资源可转化为日后更好的认知功能,尤其是在边缘化人群中。
{"title":"State-Level Education Quality and Trajectories of Cognitive Function by Race and Educational Attainment.","authors":"Katrina M Walsemann, Heide Jackson, Emily Abbruzzi, Jennifer A Ailshire","doi":"10.1111/1468-0009.12709","DOIUrl":"10.1111/1468-0009.12709","url":null,"abstract":"<p><p>Policy Points Education-cognition research overlooks the role of education quality in shaping cognitive function at midlife and older ages, even though quality may be more responsive to federal and state investment in public schooling than attainment. For older US adults who attended school during the early to mid-20th century, the quality of US education improved considerably as federal and state investment increased. Ensuring access to high-quality primary and secondary education may protect against poor cognitive function at midlife and older ages, particularly among Black Americans and persons who complete less education. It may also play an important role in reducing health inequities.</p><p><strong>Context: </strong>Although educational attainment is consistently associated with better cognitive function among older adults, we know little about how education quality is related to cognitive function. This is a key gap in the literature given that the quality of US education improved considerably during the early to mid-20th century as state and federal investment increased. We posit that growing up in states with higher-quality education systems may protect against poor cognitive function, particularly among Black adults and adults who completed fewer years of school.</p><p><strong>Methods: </strong>We used prospective data on cognitive function from the Health and Retirement Study linked to historical data on state investment in public schools, restricting our sample to non-Hispanic White and Black adults born between 1914 and 1959 (19,096 White adults and 4,625 Black adults). Using race-stratified linear mixed models, we considered if state-level education quality was associated with level and decline in cognitive function and if these patterns differed by years of schooling and race.</p><p><strong>Findings: </strong>Residing in states with higher-resourced education systems during childhood was associated with better cognitive function, particularly among those who completed less than 12 years of schooling, regardless of race. For White adults, higher-resourced state education systems were associated with higher scores of total cognitive function and episodic memory, but there were diminishing returns as resources increased to very high levels. For Black adults, the relationship between state education resources and cognitive function varied by age with positive associations in midlife and generally null or negative associations at the oldest ages.</p><p><strong>Conclusions: </strong>Federal and state investment in public schools may provide students with opportunities to develop important cognitive resources during schooling that translate into better cognitive function in later life, especially among marginalized populations.</p>","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"765-821"},"PeriodicalIF":4.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Spectrum of State Approaches to Medicaid Maternity Care Contracting. 各州对医疗补助孕产妇护理合同的处理方式。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-09-01 Epub Date: 2024-06-12 DOI: 10.1111/1468-0009.12707
Caitlin Murphy, Anne Rossier Markus, Rebecca Morris, Kay Johnson, Sara Rosenbaum, Laurie C Zephyrin

Policy Points Maternal health is influenced by the quality and accessibility of care before, during, and after pregnancy. Nationwide, Medicaid covers nearly one in two births and uses managed care as a central means for carrying out these responsibilities. Thus, managed care plays a fundamental role in assuring timely, equitable, quality care and improving maternal health outcomes. A close review of managed care contracts makes evident that the absence of a national set of maternal health standards has caused challenges in setting expectations for managed care performance. State Medicaid agencies adopt a variety of approaches and underlying philosophies for contracting.

Context: Managed care is how Medicaid agencies principally furnish maternity care. For this reason, the contracts that Medicaid agencies enter into with managed care organizations have attracted strong interest as a means of improving maternal health access, quality, and equity. However, limited research has documented the extent to which states use these agreements to set binding expectations across the maternal health continuum and how states approach the task of maternal health contracting.

Methods: To explore maternal health contracting within Medicaid Managed Care, this study took a three-phase, sequential approach: (1) an extensive literature review to identify clinical guidelines and expert recommendations regarding maternal health "best practices" for people with elevated health and social needs, (2) a review of the managed care contracts in use across 40 states and Washington, DC, to determine the extent to which they incorporate these best practices, and (3) interviews conducted with four state Medicaid agencies to better understand how states approach maternal health when developing their contracts.

Findings: The evidence on maternal health best practices reveals nearly 60 "best practices," although the literature review also underscored the extent to which these recommendations are fragmented across numerous professional bodies and government agencies and are thus difficult for Medicaid agencies to ascertain. The contracts themselves reflect an approach to the maternal health continuum in a fragmented and incomplete way. Thematic analysis of interviews with state Medicaid agencies revealed three key approaches to contracting for maternity care: an "organic" approach, an "intentional" approach, and an approach "grounded" in state strategy.

Conclusions: The absence of comprehensive, integrated guidelines reflecting the full maternal health continuum likely complicates the contracting task and contributes to incomplete, ambiguous contracts. A major step would be the development of a "best practices tool" that helps state Medicaid agencies translate evidence into comprehensive, clear contracting expectations.

政策要点 孕产妇健康受到孕前、孕期和产后护理质量和可及性的影响。在全国范围内,医疗补助(Medicaid)覆盖了几乎每两个新生儿中的一个,并将管理式医疗作为履行这些职责的核心手段。因此,管理性医疗在确保及时、公平、优质的医疗服务和改善孕产妇健康状况方面发挥着重要作用。对管理性医疗合同的仔细审查表明,由于缺乏一套全国性的孕产妇健康标准,在设定对管理性医疗绩效的期望时遇到了挑战。各州的医疗补助(Medicaid)机构采用不同的方法和基本理念来签订合同:管理式医疗是医疗补助机构提供孕产妇医疗服务的主要方式。因此,医疗补助机构与管理性医疗机构签订的合同作为一种改善孕产妇医疗服务、提高质量和公平性的手段,引起了人们的强烈兴趣。然而,关于各州在多大程度上利用这些协议来设定孕产妇保健连续性的约束性预期,以及各州如何处理孕产妇保健合同任务的研究记录有限:为了探索医疗补助管理性护理中的孕产妇健康合同,本研究采取了三阶段顺序方法:(1)广泛的文献综述,以确定针对健康和社会需求较高人群的孕产妇健康 "最佳实践 "的临床指南和专家建议;(2)对 40 个州和华盛顿特区正在使用的管理性护理合同进行审查,以确定这些合同在多大程度上纳入了这些最佳实践;(3)对四个州的医疗补助机构进行访谈,以更好地了解各州在制定合同时如何处理孕产妇健康问题:有关孕产妇保健最佳实践的证据揭示了近 60 种 "最佳实践",尽管文献综述也强调了这些建议分散在众多专业团体和政府机构中的程度,因此医疗补助机构难以确定。合同本身也反映出孕产妇保健的连续性是零散和不完整的。通过对各州医疗补助机构的访谈进行专题分析,发现了签订孕产妇保健合同的三种主要方法:"有机 "方法、"有意 "方法和 "基于 "州战略的方法:结论:缺乏反映孕产妇健康全过程的全面综合指南可能会使签约任务复杂化,并导致合同不完整、不明确。一个重要的步骤是开发 "最佳实践工具",帮助州医疗补助机构将证据转化为全面、明确的合同预期。
{"title":"The Spectrum of State Approaches to Medicaid Maternity Care Contracting.","authors":"Caitlin Murphy, Anne Rossier Markus, Rebecca Morris, Kay Johnson, Sara Rosenbaum, Laurie C Zephyrin","doi":"10.1111/1468-0009.12707","DOIUrl":"10.1111/1468-0009.12707","url":null,"abstract":"<p><p>Policy Points Maternal health is influenced by the quality and accessibility of care before, during, and after pregnancy. Nationwide, Medicaid covers nearly one in two births and uses managed care as a central means for carrying out these responsibilities. Thus, managed care plays a fundamental role in assuring timely, equitable, quality care and improving maternal health outcomes. A close review of managed care contracts makes evident that the absence of a national set of maternal health standards has caused challenges in setting expectations for managed care performance. State Medicaid agencies adopt a variety of approaches and underlying philosophies for contracting.</p><p><strong>Context: </strong>Managed care is how Medicaid agencies principally furnish maternity care. For this reason, the contracts that Medicaid agencies enter into with managed care organizations have attracted strong interest as a means of improving maternal health access, quality, and equity. However, limited research has documented the extent to which states use these agreements to set binding expectations across the maternal health continuum and how states approach the task of maternal health contracting.</p><p><strong>Methods: </strong>To explore maternal health contracting within Medicaid Managed Care, this study took a three-phase, sequential approach: (1) an extensive literature review to identify clinical guidelines and expert recommendations regarding maternal health \"best practices\" for people with elevated health and social needs, (2) a review of the managed care contracts in use across 40 states and Washington, DC, to determine the extent to which they incorporate these best practices, and (3) interviews conducted with four state Medicaid agencies to better understand how states approach maternal health when developing their contracts.</p><p><strong>Findings: </strong>The evidence on maternal health best practices reveals nearly 60 \"best practices,\" although the literature review also underscored the extent to which these recommendations are fragmented across numerous professional bodies and government agencies and are thus difficult for Medicaid agencies to ascertain. The contracts themselves reflect an approach to the maternal health continuum in a fragmented and incomplete way. Thematic analysis of interviews with state Medicaid agencies revealed three key approaches to contracting for maternity care: an \"organic\" approach, an \"intentional\" approach, and an approach \"grounded\" in state strategy.</p><p><strong>Conclusions: </strong>The absence of comprehensive, integrated guidelines reflecting the full maternal health continuum likely complicates the contracting task and contributes to incomplete, ambiguous contracts. A major step would be the development of a \"best practices tool\" that helps state Medicaid agencies translate evidence into comprehensive, clear contracting expectations.</p>","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"692-712"},"PeriodicalIF":4.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576584/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141312127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Policy Recommendations for Coordinated and Sustainable Growth of the Behavioral Health Workforce. 关于行为健康工作人员队伍协调和可持续增长的政策建议。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-09-01 Epub Date: 2024-07-23 DOI: 10.1111/1468-0009.12711
Briana S Last, Erika L Crable

Policy Points Demand for behavioral health services outpaces the capacity of the existing workforce, and the unmet need for behavioral health services is expected to grow. This paper summarizes research and policy evidence demonstrating that the long-standing challenges that impede behavioral health workforce development and retention (i.e., low wages, high workloads, training gaps) are being replicated by growing efforts to expand the workforce through task-sharing delivery to nonspecialist behavioral health providers (e.g., peer specialists, promotores de salud). In this paper, we describe policy opportunities to sustain behavioral health workforce growth to meet demand while supporting fair wages, labor protections, and rigorous training.

政策要点 对行为健康服务的需求超过了现有劳动力的能力,预计未得到满足的行为健康服务需求还将增长。本文总结的研究和政策证据表明,长期以来阻碍行为健康人才队伍发展和保留的挑战(即工资低、工作量大、培训缺口),正通过向非专业行为健康服务提供者(如同伴专家、健康促进者)提供任务分担服务的方式不断扩大人才队伍。在本文中,我们阐述了在支持公平工资、劳动保护和严格培训的同时,维持行为健康劳动力增长以满足需求的政策机遇。
{"title":"Policy Recommendations for Coordinated and Sustainable Growth of the Behavioral Health Workforce.","authors":"Briana S Last, Erika L Crable","doi":"10.1111/1468-0009.12711","DOIUrl":"10.1111/1468-0009.12711","url":null,"abstract":"<p><p>Policy Points Demand for behavioral health services outpaces the capacity of the existing workforce, and the unmet need for behavioral health services is expected to grow. This paper summarizes research and policy evidence demonstrating that the long-standing challenges that impede behavioral health workforce development and retention (i.e., low wages, high workloads, training gaps) are being replicated by growing efforts to expand the workforce through task-sharing delivery to nonspecialist behavioral health providers (e.g., peer specialists, promotores de salud). In this paper, we describe policy opportunities to sustain behavioral health workforce growth to meet demand while supporting fair wages, labor protections, and rigorous training.</p>","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"526-543"},"PeriodicalIF":4.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576582/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacts of State-Level Opioid Review Programs on Injured Workers and Their Health Care Providers: A Qualitative Study in Washington and Ohio. 州级阿片类药物审查计划对受伤工人及其医疗服务提供者的影响:华盛顿州和俄亥俄州的定性研究。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-09-01 Epub Date: 2024-06-11 DOI: 10.1111/1468-0009.12705
Tasleem J Padamsee, Courtni Montgomery, Stefan Kienzle, Jeremy B Straughn, Andrea Elmore, Deborah L Fulton-Kehoe, Beryl Schulman, Thomas M Wickizer, Gary M Franklin
<p><p>Policy Points Workers' compensation agencies have instituted opioid review policies to reduce unsafe prescribing. Providers reported more limited and cautious prescribing than in the past; both patients and providers reported collaborative pain-management relationships and satisfactory pain control for patients. Despite the fears articulated by pharmaceutical companies and patient advocates, opioid review programs have not generally resulted in unmanaged pain or reduced function in patients, anger or resistance from patients or providers, or damage to patient-provider relationships or clinical autonomy. Other insurance providers with broad physician networks may want to consider similar quality-improvement efforts to support safe opioid prescribing.</p><p><strong>Context: </strong>Unsafe prescribing practices have been among the central causes of improper reception of opioids, unsafe use, and overdose in the United States. Workers' compensation agencies in Washington and Ohio have implemented opioid review programs (ORPs)-a form of quality improvement based on utilization review-to curb unsafe prescribing. Evidence suggests that such regulations indeed reduce unsafe prescribing, but pharmaceutical companies and patient advocates have raised concerns about negative impacts that could also result. This study explores whether three core sets of problems have actually come to pass: (1) unmanaged pain or reduced function among patients, (2) anger or resistance to ORPs from patients or providers, and (3) damage to patient-provider relationships or clinical autonomy.</p><p><strong>Methods: </strong>In-depth semistructured interviews were conducted with 48 patients (21 from Washington, 27 from Ohio) and 32 providers (18 from Washington, 14 from Ohio) who were purposively sampled to represent a range of injury and practice types. Thematic coding was conducted with codebooks developed using both inductive and deductive approaches.</p><p><strong>Findings: </strong>The consequences of opioid regulations have been generally positive: providers report more limited prescribing and a focus on multimodal pain control; patients report satisfactory pain control and recovery alongside collaborative relationships with providers. Participants attribute these patterns to a broad environment of opioid caution; they do not generally perceive workers' compensation policies as distinctly impactful. Both patients and providers comment frequently on the difficult aspects of interacting with workers' compensation agencies; effects of these range from simple inconvenience to delays in care, unmanaged pain, and reduced potential for physical recovery.</p><p><strong>Conclusions: </strong>In general, the three types of feared negative impacts have not come to pass for either patients or providers. Although interacting with workers' compensation agencies involves difficulties typical of interacting with other insurers, opioid controls seem to have generally positive effects
政策要点 工人赔偿机构已经制定了阿片类药物审查政策,以减少不安全的处方。医疗服务提供者表示,与过去相比,他们开出的处方更加有限和谨慎;患者和医疗服务提供者都表示,双方建立了合作的疼痛管理关系,患者的疼痛控制效果令人满意。尽管制药公司和患者权益倡导者表达了他们的担忧,但阿片类药物审查计划一般不会导致患者疼痛得不到控制或功能减退,不会引起患者或医疗服务提供者的愤怒或抵制,也不会损害患者与医疗服务提供者的关系或临床自主权。其他拥有广泛医生网络的保险提供商可能会考虑采取类似的质量改进措施,以支持阿片类药物的安全处方:不安全的处方行为是美国阿片类药物接收不当、使用不安全和用药过量的主要原因之一。华盛顿州和俄亥俄州的工伤赔偿机构实施了阿片类药物审查计划(ORPs)--一种基于使用审查的质量改进形式,以遏制不安全处方。有证据表明,此类规定确实减少了不安全处方的开具,但制药公司和患者权益倡导者也对可能产生的负面影响表示担忧。本研究探讨了三类核心问题是否真的发生了:(1)患者的疼痛得不到控制或功能减退;(2)患者或医疗服务提供者对 ORPs 感到愤怒或抵触;以及(3)患者与医疗服务提供者的关系或临床自主权受到损害:对 48 名患者(21 名来自华盛顿州,27 名来自俄亥俄州)和 32 名医疗服务提供者(18 名来自华盛顿州,14 名来自俄亥俄州)进行了深入的半结构式访谈。采用归纳法和演绎法编制的编码手册进行了主题编码:阿片类药物管理条例的影响总体上是积极的:医疗服务提供者报告说,他们开出了更有限的处方,并注重多模式疼痛控制;患者报告说,他们对疼痛控制和康复以及与医疗服务提供者的合作关系感到满意。参与者将这些模式归因于对阿片类药物持谨慎态度的大环境;他们普遍认为工伤赔偿政策不会产生明显影响。患者和医疗服务提供者经常谈到与工伤赔偿机构互动的困难之处;这些影响包括简单的不便、护理延误、疼痛得不到控制以及身体恢复潜力下降等:总的来说,患者和医疗服务提供者所担心的三种负面影响都没有发生。尽管与工伤赔偿机构互动时会遇到与其他保险公司互动时常见的困难,但阿片类药物管制措施似乎总体上产生了积极的影响,并得到了普遍的好评。
{"title":"Impacts of State-Level Opioid Review Programs on Injured Workers and Their Health Care Providers: A Qualitative Study in Washington and Ohio.","authors":"Tasleem J Padamsee, Courtni Montgomery, Stefan Kienzle, Jeremy B Straughn, Andrea Elmore, Deborah L Fulton-Kehoe, Beryl Schulman, Thomas M Wickizer, Gary M Franklin","doi":"10.1111/1468-0009.12705","DOIUrl":"10.1111/1468-0009.12705","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Policy Points Workers' compensation agencies have instituted opioid review policies to reduce unsafe prescribing. Providers reported more limited and cautious prescribing than in the past; both patients and providers reported collaborative pain-management relationships and satisfactory pain control for patients. Despite the fears articulated by pharmaceutical companies and patient advocates, opioid review programs have not generally resulted in unmanaged pain or reduced function in patients, anger or resistance from patients or providers, or damage to patient-provider relationships or clinical autonomy. Other insurance providers with broad physician networks may want to consider similar quality-improvement efforts to support safe opioid prescribing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Context: &lt;/strong&gt;Unsafe prescribing practices have been among the central causes of improper reception of opioids, unsafe use, and overdose in the United States. Workers' compensation agencies in Washington and Ohio have implemented opioid review programs (ORPs)-a form of quality improvement based on utilization review-to curb unsafe prescribing. Evidence suggests that such regulations indeed reduce unsafe prescribing, but pharmaceutical companies and patient advocates have raised concerns about negative impacts that could also result. This study explores whether three core sets of problems have actually come to pass: (1) unmanaged pain or reduced function among patients, (2) anger or resistance to ORPs from patients or providers, and (3) damage to patient-provider relationships or clinical autonomy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;In-depth semistructured interviews were conducted with 48 patients (21 from Washington, 27 from Ohio) and 32 providers (18 from Washington, 14 from Ohio) who were purposively sampled to represent a range of injury and practice types. Thematic coding was conducted with codebooks developed using both inductive and deductive approaches.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Findings: &lt;/strong&gt;The consequences of opioid regulations have been generally positive: providers report more limited prescribing and a focus on multimodal pain control; patients report satisfactory pain control and recovery alongside collaborative relationships with providers. Participants attribute these patterns to a broad environment of opioid caution; they do not generally perceive workers' compensation policies as distinctly impactful. Both patients and providers comment frequently on the difficult aspects of interacting with workers' compensation agencies; effects of these range from simple inconvenience to delays in care, unmanaged pain, and reduced potential for physical recovery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In general, the three types of feared negative impacts have not come to pass for either patients or providers. Although interacting with workers' compensation agencies involves difficulties typical of interacting with other insurers, opioid controls seem to have generally positive effects ","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"605-631"},"PeriodicalIF":4.8,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reforming Physician Licensure in the United States to Improve Access to Telehealth: State, Regional, and Federal Initiatives. 改革美国医生执照制度以改善远程医疗的可及性:州、地区和联邦倡议。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-08-19 DOI: 10.1111/1468-0009.12713
James René Jolin, Barak Richman, Ateev Mehrotra, Carmel Shachar

Policy Points The reinstitution of pre-COVID-19 pandemic licensure regulations has impeded interstate telehealth. This has disproportionately impacted patients who live near a state border; geographically mobile patients, such as college students; and patients with rare diseases who may need care from a specialist outside their state. Several promising and feasible reforms are available, at both state and federal levels, to facilitate interstate telehealth. For example, states can offer exemptions to licensure requirements for certain types of telehealth such as follow-up care or create licensure registries that impose little reduced paperwork and fees on physicians. On the federal level, congressional interventions that mimic the Department of Veterans Affairs Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018 can waive provider licensing and geographic restrictions to telehealth within certain federal programs such as Medicare. Any discussion of medical licensure reform, however, must also consider the current political climate, one in which states are taking divergent stances on sensitive topics such as reproductive care, gender-affirming care, and substance use treatments.

政策要点 19 年大流行之前的 COVID 许可法规的恢复阻碍了州际远程医疗的发展。这对居住在州边界附近的患者、地域流动性强的患者(如大学生)以及可能需要州外专科医生治疗的罕见病患者造成了极大的影响。为了促进州际远程医疗,州和联邦层面都有几项有前景且可行的改革措施。例如,各州可以为某些类型的远程医疗(如随访护理)提供执照要求豁免,或建立执照登记制度,减少医生的文书工作和费用。在联邦层面,模仿退伍军人事务部《2018 年维护内部系统和加强综合外部网络(VA MISSION)法案》的国会干预措施,可以免除某些联邦计划(如医疗保险)中对远程医疗的提供商许可和地域限制。然而,任何有关医疗执照改革的讨论都必须考虑到当前的政治气候,即各州对生殖保健、性别肯定护理和药物使用治疗等敏感话题采取不同的立场。
{"title":"Reforming Physician Licensure in the United States to Improve Access to Telehealth: State, Regional, and Federal Initiatives.","authors":"James René Jolin, Barak Richman, Ateev Mehrotra, Carmel Shachar","doi":"10.1111/1468-0009.12713","DOIUrl":"https://doi.org/10.1111/1468-0009.12713","url":null,"abstract":"<p><p>Policy Points The reinstitution of pre-COVID-19 pandemic licensure regulations has impeded interstate telehealth. This has disproportionately impacted patients who live near a state border; geographically mobile patients, such as college students; and patients with rare diseases who may need care from a specialist outside their state. Several promising and feasible reforms are available, at both state and federal levels, to facilitate interstate telehealth. For example, states can offer exemptions to licensure requirements for certain types of telehealth such as follow-up care or create licensure registries that impose little reduced paperwork and fees on physicians. On the federal level, congressional interventions that mimic the Department of Veterans Affairs Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018 can waive provider licensing and geographic restrictions to telehealth within certain federal programs such as Medicare. Any discussion of medical licensure reform, however, must also consider the current political climate, one in which states are taking divergent stances on sensitive topics such as reproductive care, gender-affirming care, and substance use treatments.</p>","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":""},"PeriodicalIF":4.8,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asking MultiCrit Questions: A Reflexive and Critical Framework to Promote Health Data Equity for the Multiracial Population. 提出多重批判性问题:促进多种族人口健康数据平等的反思性和批判性框架》(A Reflexive and Critical Framework to Promote Health Data Equity for the Multiracial Population)。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-06-01 Epub Date: 2024-02-29 DOI: 10.1111/1468-0009.12696
Tracy Lam-Hine, Sarah Forthal, Candice Y Johnson, Helen B Chin

Policy Points Health equity work primarily centers monoracial populations; however, the rapid growth of the Multiracial population and increasingly clear health disparities affecting the people in that population complicate our understanding of racial health equity. Limited resources exist for health researchers and professionals grappling with this complexity, likely contributing to the relative dearth of health literature describing the Multiracial population. We introduce a question-based framework built on core principles from Critical Multiracial Theory (MultiCrit) and Critical Race Public Health Praxis, designed for researchers, clinicians, and policymakers to encourage health data equity for the Multiracial population.

政策要点 健康公平工作主要以单一种族人口为中心;然而,多种族人口的快速增长以及影响该人口的健康差距日益明显,使我们对种族健康公平的理解变得更加复杂。健康研究人员和专业人员在应对这一复杂问题时所获得的资源有限,这可能是导致描述多种族人口的健康文献相对匮乏的原因之一。我们介绍了一个基于问题的框架,该框架建立在批判性多种族理论(MultiCrit)和批判性种族公共卫生实践的核心原则之上,专为研究人员、临床医生和政策制定者设计,旨在促进多种族人口的健康数据公平。
{"title":"Asking MultiCrit Questions: A Reflexive and Critical Framework to Promote Health Data Equity for the Multiracial Population.","authors":"Tracy Lam-Hine, Sarah Forthal, Candice Y Johnson, Helen B Chin","doi":"10.1111/1468-0009.12696","DOIUrl":"10.1111/1468-0009.12696","url":null,"abstract":"<p><p>Policy Points Health equity work primarily centers monoracial populations; however, the rapid growth of the Multiracial population and increasingly clear health disparities affecting the people in that population complicate our understanding of racial health equity. Limited resources exist for health researchers and professionals grappling with this complexity, likely contributing to the relative dearth of health literature describing the Multiracial population. We introduce a question-based framework built on core principles from Critical Multiracial Theory (MultiCrit) and Critical Race Public Health Praxis, designed for researchers, clinicians, and policymakers to encourage health data equity for the Multiracial population.</p>","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"398-428"},"PeriodicalIF":4.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature. 评估 340B 药品定价计划的影响:同行评议文献实证范围综述》(A Scoping Review of the Empirical, Peer-Reviewed Literature.
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-06-01 Epub Date: 2024-01-28 DOI: 10.1111/1468-0009.12691
Timothy W Levengood, Rena M Conti, Sean Cahill, Megan B Cole
<p><p>Policy Points The 340B Drug Pricing Program accounts for roughly 1 out of every 100 dollars spent in the $4.3 trillion US health care industry. Decisions affecting the program will have wide-ranging consequences throughout the US safety net. Our scoping review provides a roadmap of the questions being asked about the 340B program and an initial synthesis of the answers. The highest-quality evidence indicates that nonprofit, disproportionate share hospitals may be using the 340B program in margin-motivated ways, with inconsistent evidence for increased safety net engagement; however, this finding is not consistent across other hospital types and public health clinics, which face different incentive structures and reporting requirements.</p><p><strong>Context: </strong>Despite remarkable growth and relevance of the 340B Drug Pricing Program to current health care practice and policy debate, academic literature examining 340B has lagged. The objectives of this scoping review were to summarize i) common research questions published about 340B, ii) what is empirically known about 340B and its implications, and iii) remaining knowledge gaps, all organized in a way that is informative to practitioners, researchers, and decision makers.</p><p><strong>Methods: </strong>We conducted a scoping review of the peer-reviewed, empirical 340B literature (database inception to March 2023). We categorized studies by suitability of their design for internal validity, type of covered entity studied, and motivation-by-scope category.</p><p><strong>Findings: </strong>The final yield included 44 peer-reviewed, empirical studies published between 2003 and 2023. We identified 15 frequently asked research questions in the literature, across 6 categories of inquiry-motivation (margin or mission) and scope (external, covered entity, and care delivery interface). Literature with greatest internal validity leaned toward evidence of margin-motivated behavior at the external environment and covered entity levels, with inconsistent findings supporting mission-motivated behavior at these levels; this was particularly the case among participating disproportionate share hospitals (DSHs). However, included case studies were unanimous in demonstrating positive effects of the 340B program for carrying out a provider's safety net mission.</p><p><strong>Conclusions: </strong>In our scoping review of the 340B program, the highest-quality evidence indicates nonprofit, DSHs may be using the 340B program in margin-motivated ways, with inconsistent evidence for increased safety net engagement; however, this finding is not consistent across other hospital types and public health clinics, which face different incentive structures and reporting requirements. Future studies should examine heterogeneity by covered entity types (i.e., hospitals vs. public health clinics), characteristics, and time period of 340B enrollment. Our findings provide additional context to current health policy disc
政策要点 340B 药品定价计划约占美国 4.3 万亿美元医疗保健行业每 100 美元支出中的 1%。影响该计划的决策将对整个美国安全网产生广泛的影响。我们的范围综述提供了有关 340B 计划问题的路线图,并对答案进行了初步归纳。质量最高的证据表明,非营利性、比例过大的医院可能会在利润的驱动下使用 340B 计划,但关于安全网参与度提高的证据并不一致;然而,这一结论在其他类型的医院和公共卫生诊所中并不一致,因为它们面临着不同的激励结构和报告要求:背景:尽管 340B 药品定价计划取得了长足发展,并与当前的医疗实践和政策辩论密切相关,但研究 340B 的学术文献却十分滞后。本范围综述的目的是总结 i) 已发表的有关 340B 的常见研究问题;ii) 有关 340B 及其影响的经验知识;iii) 尚存在的知识差距,所有这些都以对从业人员、研究人员和决策者具有参考价值的方式进行组织:我们对经同行评审的 340B 实证文献进行了一次范围界定审查(从数据库建立到 2023 年 3 月)。我们按照内部有效性设计的适宜性、所研究的承保实体类型以及按范围类别划分的动机对研究进行了分类:最终结果包括 2003 年至 2023 年间发表的 44 项经同行评审的实证研究。我们在文献中发现了 15 个常见的研究问题,涉及 6 个调查类别--动机(边际或使命)和范围(外部、承保实体和医疗服务界面)。内部有效性最高的文献倾向于证明在外部环境和承保实体层面存在以利润为动机的行为,而支持在这些层面存在以使命为动机的行为的研究结果并不一致;这在参与的不成比例份额医院(DSHs)中尤为明显。然而,所纳入的案例研究一致表明,340B 计划对医疗服务提供者履行安全网使命具有积极作用:在我们对 340B 计划进行的范围审查中,最高质量的证据表明非营利性 DSH 医院可能会以利润为动机的方式使用 340B 计划,但关于安全网参与度提高的证据并不一致;然而,这一结论在其他医院类型和公共卫生诊所中并不一致,因为它们面临不同的激励结构和报告要求。未来的研究应根据承保实体的类型(即医院与公共卫生诊所)、特征和 340B 注册的时间段来研究异质性。我们的研究结果为当前有关 340B 计划的卫生政策讨论提供了更多的背景资料。
{"title":"Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature.","authors":"Timothy W Levengood, Rena M Conti, Sean Cahill, Megan B Cole","doi":"10.1111/1468-0009.12691","DOIUrl":"10.1111/1468-0009.12691","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Policy Points The 340B Drug Pricing Program accounts for roughly 1 out of every 100 dollars spent in the $4.3 trillion US health care industry. Decisions affecting the program will have wide-ranging consequences throughout the US safety net. Our scoping review provides a roadmap of the questions being asked about the 340B program and an initial synthesis of the answers. The highest-quality evidence indicates that nonprofit, disproportionate share hospitals may be using the 340B program in margin-motivated ways, with inconsistent evidence for increased safety net engagement; however, this finding is not consistent across other hospital types and public health clinics, which face different incentive structures and reporting requirements.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Context: &lt;/strong&gt;Despite remarkable growth and relevance of the 340B Drug Pricing Program to current health care practice and policy debate, academic literature examining 340B has lagged. The objectives of this scoping review were to summarize i) common research questions published about 340B, ii) what is empirically known about 340B and its implications, and iii) remaining knowledge gaps, all organized in a way that is informative to practitioners, researchers, and decision makers.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We conducted a scoping review of the peer-reviewed, empirical 340B literature (database inception to March 2023). We categorized studies by suitability of their design for internal validity, type of covered entity studied, and motivation-by-scope category.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Findings: &lt;/strong&gt;The final yield included 44 peer-reviewed, empirical studies published between 2003 and 2023. We identified 15 frequently asked research questions in the literature, across 6 categories of inquiry-motivation (margin or mission) and scope (external, covered entity, and care delivery interface). Literature with greatest internal validity leaned toward evidence of margin-motivated behavior at the external environment and covered entity levels, with inconsistent findings supporting mission-motivated behavior at these levels; this was particularly the case among participating disproportionate share hospitals (DSHs). However, included case studies were unanimous in demonstrating positive effects of the 340B program for carrying out a provider's safety net mission.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In our scoping review of the 340B program, the highest-quality evidence indicates nonprofit, DSHs may be using the 340B program in margin-motivated ways, with inconsistent evidence for increased safety net engagement; however, this finding is not consistent across other hospital types and public health clinics, which face different incentive structures and reporting requirements. Future studies should examine heterogeneity by covered entity types (i.e., hospitals vs. public health clinics), characteristics, and time period of 340B enrollment. Our findings provide additional context to current health policy disc","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"429-462"},"PeriodicalIF":4.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139571948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multisector Collaboration vs. Social Democracy for Addressing Social Determinants of Health. 解决健康的社会决定因素的多部门合作与社会民主。
IF 4.8 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-06-01 Epub Date: 2023-12-29 DOI: 10.1111/1468-0009.12685
Seth A Berkowitz

Policy Points Multisector collaboration, the dominant approach for responding to health harms created by adverse social conditions, involves collaboration among health care insurers, health care systems, and social services organizations. Social democracy, an underused alternative, seeks to use government policy to shape the civil (e.g., civil rights), political (e.g., voting rights), and economic (e.g., labor market institutions, property rights, and the tax-and-transfer system) institutions that produce health. Multisector collaboration may not achieve its goals, both because the collaborations are difficult to accomplish and because it does not seek to transform social conditions, only to mitigate their harms. Social democracy requires political contestation but has greater potential to improve population health and health equity.

政策要点 多部门合作是应对不利社会条件对健康造成伤害的主要方法,涉及医疗保险公司、医疗保健系统和社会服务组织之间的合作。社会民主是一种未被充分利用的替代方法,它试图利用政府政策来塑造产生健康的公民(如公民权利)、政治(如投票权)和经济(如劳动力市场制度、财产权和税收与转移制度)制度。多部门合作可能无法实现其目标,一是因为合作难以实现,二是因为它并不寻求改变社会状况,而只是减轻其危害。社会民主需要政治竞争,但在改善人口健康和卫生公平方面具有更大的潜力。
{"title":"Multisector Collaboration vs. Social Democracy for Addressing Social Determinants of Health.","authors":"Seth A Berkowitz","doi":"10.1111/1468-0009.12685","DOIUrl":"10.1111/1468-0009.12685","url":null,"abstract":"<p><p>Policy Points Multisector collaboration, the dominant approach for responding to health harms created by adverse social conditions, involves collaboration among health care insurers, health care systems, and social services organizations. Social democracy, an underused alternative, seeks to use government policy to shape the civil (e.g., civil rights), political (e.g., voting rights), and economic (e.g., labor market institutions, property rights, and the tax-and-transfer system) institutions that produce health. Multisector collaboration may not achieve its goals, both because the collaborations are difficult to accomplish and because it does not seek to transform social conditions, only to mitigate their harms. Social democracy requires political contestation but has greater potential to improve population health and health equity.</p>","PeriodicalId":49810,"journal":{"name":"Milbank Quarterly","volume":" ","pages":"280-301"},"PeriodicalIF":4.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139075727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Milbank Quarterly
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1